RRMM
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients (NCT04412707) | Oncopeptides AB | 2020-08-04 |
| Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells (NCT03778346) | The Sixth Affiliated Hospital of Wenzhou Medical University | 2018-11-15 |
| Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155) (NCT02684617) | Merck Sharp & Dohme LLC | 2016-03-29 |
Track RRMM automatically
Every clearance here is in the API, with alerts when new ones post.